Surfactant composition in infants and young children with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 1, 1997, Pages 161-165

  Hull, Jeremy ^a   South, Michael ^b   Phelan, Peter ^b   Grimwood, Keith ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

AEROSOL; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; ELECTROLYTE BALANCE; EPITHELIUM CELL; FEMALE; HOST RESISTANCE; HUMAN; INFANT; LIPID COMPOSITION; LUNG DISEASE; LUNG LAVAGE; MALE; MUCOCILIARY CLEARANCE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; VISCOSITY;

EID: 0030788625     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.1.9609090     Document Type: Article

References (26)

1. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelial cells fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
2. Morgenroth, K., and J. Bolz. 1985. Morphological features of the interaction between mucus and surfactant on the bronchial mucosa. Respiration 47:225-231.
3. Lui, M., L. Wang, and G. Enhorning. 1991. Pulmonary Surfactant will secure free airflow through a narrow tube. J. Appl. Physiol. 71:742-748.
4. Rubin, B. K., O. Ramirez, and M. King. 1992. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy. Chest 101:1080-1085.
5. Kakuta, Y., H. Sasaki, and T. Takishima. 1991. Effect of artificial surfactant on ciliary beat frequency in guinea-pig trachea. Respiration Physiol. 83:313-321.
6. Manz-Keinke, H., H. Plattner, and J. Schlepper-Schafer. 1992. Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Eur. J. Cell. Biol. 57:95-100.
7. Hills, B. A. 1996. Asthma: is there an airway receptor barrier? Thorax 51:773-776.
8. Gilljam, H., O. Andersson, A. Ellin, B. Robertson, and B. Standvik. 1988. Composition and surface properties of the bronchial lipids in adult patients with cystic fibrosis. Clin. Chim. Acta 176:29-37.
9. Girod, S., C. Galabert, A. Lecuire, J. M. Zahm, and E. Puchelle. 1992. Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases. Pediatr. Pulmonol. 13:22-27.
10. Meyer, K., M. Weatherly, J. Lewandoski, and J. Zimmerman. 1992. Surfactant dysfunction in cystic fibrosis. Chest 102(Suppl.):85S.
11. Rubin, B. K., O. E. Ramirez, E. Smith, and J. Barrett. 1995. Early results of clinical trials of exosurf for the therapy of cystic fibrosis lung disease. Pediatr. Pulmonol. 12:234.
12. Armstrong, D. A., K. Grimwood, J. B. Carlin, R. Carzino, A. Olinsky, and P. D. Phelan. 1996. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr. Pulmonol. 21:267-275.
13. Bligh, E. G., W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 27:911-917.
14. Mason, R. J., J. Nellenbogen, and J. A. Clements. 1976. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J. Lipid Res. 17: 281-284.
15. Bartlett, G. R. 1959. Phosphorous assay in column chromatography. J. Biol. Chem. 234:466-468.
16. Doyle, I. R., M. E. Jones, H. A. Barr, S. Orgeig, A. J. Crockett, C. F. Mcdonald, and T. E. Nicholas. 1994. Composition of human pulmonary surfactant varies with exercise and level of fitness. Am. J. Respir. Crit. Care Med. 149:1619-1627.
17. Yogalingham, G., I. R. Doyle, and J. H. T. Power. 1996. Expression and distribution of surfactant proteins and lysozyme after prolonged hyperpnoea. Am. J. Physiol. 270:L320-L330.
18. Enhorning, G. 1977. Pulsating bubble technique for evaluating pulmonary surfactant. J. Appl. Physiol. 43:198-203.
19. Dargaville, P. A., M. South, and P. N. McDougall. 1996. Surfactant abnormalities in infants with severe viral bronchiolitis. Arch. Dis. Child. 75:133-136.
20. Holm, B. A., L. Keicher, M. Liu, J. Sokolowski, and G. Enhorning. 1991. Inhibition of pulmonary surfactant function by phospholipases. J. Appl. Physiol. 71:317-321.
21. Ratjen, F., B. Rehn, U. Costabel, and J. Bruch. 1996. Age-dependency of surfactant phospholipids and surfactant protein A in bronchoalveolar lavage fluid of children without bronchopulmonary disease. Eur. Respir. J. 9:328-333.
22. Baughman, R. P., R. I. Sternberg, W. Hull, J. Buchsbaum, and J. A. Whitsett. 1993. Decreased surfactant protein A in patients with bacterial pneumonia. Am. Rev. Respir. Dis. 147:653-657.
23. Gunther, A., C. Siebert, R. Schmidt, S. Ziegler, F. Grimmenger, M. Yabut, B. Temmesfeld, D. Walmrath, H. Morr, and W. Seeger. 1996. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am. J. Respir. Crit. Care Med. 153:176-184.
24. Sternberg, R. I., J. A. Whitsett, W. M. Hull, and R. P. Baughman. 1995. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid. J. Lab. Clin. Med. 125:462-469.
25. Auten, R. L., R. H. Watkins, D. L. Shapiro, and S. Horowitz. 1990. Surfactant apoprotein A (SP-A) is synthesised in airway cells. Am. J. Respir. Cell Mol. Biol. 3:491-496.
26. Khoor, A., M. E. Gray, W. M. Hull, J. A. Whitsett, and M. T. Stahlman. 1993. Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. J. Histochem. Cytochem. 41:1311-1319.